Cargando…

Breaking the allergic response by disrupting antibody glycosylation

Detalles Bibliográficos
Autor principal: Crispin, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387280/
https://www.ncbi.nlm.nih.gov/pubmed/25847971
http://dx.doi.org/10.1084/jem.2124insight2
_version_ 1782365251176497152
author Crispin, Max
author_facet Crispin, Max
author_sort Crispin, Max
collection PubMed
description
format Online
Article
Text
id pubmed-4387280
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-43872802015-10-06 Breaking the allergic response by disrupting antibody glycosylation Crispin, Max J Exp Med News The Rockefeller University Press 2015-04-06 /pmc/articles/PMC4387280/ /pubmed/25847971 http://dx.doi.org/10.1084/jem.2124insight2 Text en Copyright © 2015 by The Rockefeller University Press https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle News
Crispin, Max
Breaking the allergic response by disrupting antibody glycosylation
title Breaking the allergic response by disrupting antibody glycosylation
title_full Breaking the allergic response by disrupting antibody glycosylation
title_fullStr Breaking the allergic response by disrupting antibody glycosylation
title_full_unstemmed Breaking the allergic response by disrupting antibody glycosylation
title_short Breaking the allergic response by disrupting antibody glycosylation
title_sort breaking the allergic response by disrupting antibody glycosylation
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387280/
https://www.ncbi.nlm.nih.gov/pubmed/25847971
http://dx.doi.org/10.1084/jem.2124insight2
work_keys_str_mv AT crispinmax breakingtheallergicresponsebydisruptingantibodyglycosylation